Mainz Biomed NV
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About MYNZ
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Find out what a historical investment in Mainz Biomed NV would be worth today using our MYNZ stock calculator.
$8.76M
-
0.00%
0
$1.07
$1.02
$0.00
$8.20
$0.92
Ready to start your investing journey with Stake?
Open an accountMYNZ FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MYNZ
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MYNZ
on Stake
Buy MYNZ from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of MYNZ from only US$10 with fractional shares
